From: Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort “Visages”
Number
Age (years)
116
41.8 ± 17.5
[15-84; 39.5]
BMI (kg/m2)
23.4 ± 4.7
[15.2-40.2; 22.3]
Males
51
44.0 %
Females
65
56.0 %
Living alone
22
19.0 %
School of professional occupation
66/115
57.4 %